Developing a Chronic Disease Model of Care for Coronary Artery Disease and Depression in Rural Settings Dr Steve Bunker Prof James Dunbar Dr Prasuna Reddy.

Slides:



Advertisements
Similar presentations
NCEP ATP III Cholesterol Guidelines and Updates
Advertisements

Ischaemic Heart Disease- Implications of Gender Dr Kaye Birks School of Rural Health Monash University Australia Gender Competency Training for Medical.
PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Chronic Obstructive Pulmonary Disease Research Opportunity Chronic Obstructive Pulmonary Disease (COPD) Dr Ian Williams Greater Metro South Brisbane Medicare.
Predictors of Early Cardiovascular Disease in Children with CKD
Nonsense Mutations in PCSK9 and Cardiovascular Risk Factors among 3363 Black Participants in the Study Jonathan C.Cohen, et al, N Engl J Med 2006;354:
Doris Young, John Furler, Christine Walker, Margarite Vale, James Best, Leonie Segal, Trisha Dunning (NHMRC GP clinical research grant July ) PEACH:
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Gender Competency Training for Medical Educators 28 th of April 2003 Evidence of gender difference and its clinical significance Ann-Maree Nobelius Faculty.
HYPERLIPIDAEMIA. 4S 4444 patients –Hx angina or MI –Cholesterol Simvastatin 20mg (10-40) vs. placebo FU 5 years  total cholesterol 25%;  LDL.
Madhav Vissa. ATP III  Adult Treatment Panel  Guidelines for tx of High Cholesterol  Based on epidemiological evidence about risk factors for CHD.
What is an AEP?. AEPs specialise in clinical exercise interventions for a broad range of pathological populations.
Using research to inform and change primary care Professor James Dunbar Greater Green Triangle UDRH
New guidelines for CABG
New Zealand Cardiology Wards and Adventures Taylor Myers Locke.
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College.
Characteristics of 3921 Men Seen by a Primary Care Provider Steven A. Grover, et al, Arch Intern Med. 2005;166:
Identification of depression in diabetes: the efficacy of PHQ-9 and HADS-D by Prasuna Reddy, Benjamin Philpot, Dale Ford, and James A Dunbar BJGP Volume.
MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.
Urban-Rural Inequalities in Potentially Preventable Hospital Admissions Carolyn Hunter-Rowe Senior Health Intelligence Analyst Department of Public Health.
 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.
Baseline Characteristics of Patients Referred for Stress Myocardial Perfusion Testing by Erectile Function Classification James K. Min, et al, Arch Intern.
Presented by Slyter Nutrition Consulting Services.
Obesity in the end stage kidney disease population
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Preventing Cardiovascular Disease
Kerry-Anne Rye, Kwok Leung Ong  The Lancet Diabetes & Endocrinology 
TNT: Baseline and final LDL cholesterol levels
برنامه راهبردی پیشگیری و کنترل بیماری های قلبی عروقی
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Health and Disease Management
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit  Barry A. Franklin, PhD  Mayo.
James H. O'Keefe, M.D., Carl J. Lavie, M.D., Ben D. McCallister, M.D. 
MACE rate among CAD severity groups (total 0
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
Description of studies for pooled analyses
Kerry-Anne Rye, Kwok Leung Ong  The Lancet Diabetes & Endocrinology 
(p for noninferiority < 0.001)
Contemporary Evidence-Based Guidelines
Khurram Nasir et al. JACC 2015;66:
High Sensitivity Troponin (hsTnT) : Result Interpretation Matrix*
Effects of Pay-for-Performance on the Quality of Primary Care in England Mean Scores for Clinical Quality at the Practice Level for Aspects of Care for.
by Prasuna Reddy, Benjamin Philpot, Dale Ford, and James A Dunbar
Baseline Characteristics of Elderly Participants in the Cardiovascular Health Study,According to Quintiles of Cystatin C Michael G.Shlipak et al N Engl.
Kaplan–Meier survival curve for major adverse cardiac events (MACE): a trend towards superior survival in patients without signs of coronary artery disease.
Algorithm for the investigation of patients with elevated cardiac troponin concentrations in the context of an alternative acute illness. Algorithm for.
Asymptomatic 67-year-old man prior to orthopaedic surgery with three cardiac risk factors and borderline ST-segment depression inferior-posterior on treadmill.
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
The Heart Truth Delaware Background
Glenn N. Levine et al. JACC 2011;58:e44-e122
Potential effect of guidelines on ASCVD prevention in the CGPS*
Flow chart of the cohort selection for the study
Amir A. Mahabadi et al. JIMG 2017;10:
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
Baseline predictors for risk of cardiovascular events or all-cause mortality among immigrants with language barriers (N = 87,707). *Adjustment for all.
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR
ROC curves for cardiovascular events, all-cause mortality, and disease progression. ROC curves for cardiovascular events, all-cause mortality, and disease.
Left Ventricular Mass at MRI and Long-Term Risk of Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Left ventricular hypertrophy.
Performance of the Manchester Acute Coronary Syndromes decision rule with high-sensitivity cardiac troponin T (hs-cTnT) as the reference standard for the.
Performance of the Manchester Acute Coronary Syndromes decision rule in the validation study. Performance of the Manchester Acute Coronary Syndromes decision.
Flow diagram of study conduct.
Traditional cardiovascular risk factors can cause cardiac disease in patients with IIM. Systemic and local inflammation may either have a direct effect.
Determinants of moderate Cardiovascular Health Index Score (achieving three or more risk factor targets), stratified by region conventions as in figure.
The Ottawa COPD (chronic obstructive pulmonary disease) Risk Scale (OCRS) is used in the emergency department (ED) to identify patients with acute COPD.
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Adjusted. ORs for outcomes by maintenance P2Y12 treatment
Performance of the Manchester Acute Coronary Syndromes decision rule in the derivation study. Performance of the Manchester Acute Coronary Syndromes decision.
Presentation transcript:

Developing a Chronic Disease Model of Care for Coronary Artery Disease and Depression in Rural Settings Dr Steve Bunker Prof James Dunbar Dr Prasuna Reddy Greater Green Triangle University Department of Rural Health

The Greater Green Triangle Region

Why depression?

Background In 2003, the National Heart Foundation of Australia (NHFA) published the results of an evidence-based review which concluded that depression is an independent predictor for adverse cardiac outcomes. (Bunker S. et al. Med J Aust 2003;178:272-6) These findings have since been incorporated by the NHFA into clinical practice guidelines for preventing cardiovascular events in people with coronary heart disease. (Reducing Risk in Heart Disease. National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand, 2004.

Low RiskHigh Risk Age HT Stage 2 Smoking Diabetes LDL>160 HDL<35 Depressed Mood Clinical Depression Depression and relative risk of developing CHD

Days after MI Discharge Survival free of cardiac mortality, cumulative % Depression following myocardial infarction

Risk factorOdds ratioPAR% Abnormal lipids Cigarette smoking Psychosocial stressors Diabetes High blood pressure Abdominal obesity Yusuf, S., et al. The Lancet 3 rd Sept 2004 The INTERHEART Study

Musselman, D. et al. (1998). The Relationship of Depression to Cardiovascular Disease. Epidemiology, Biology and Treatment. Archives of General Psychiatry 55:

1. Murray and Lopez. Global Burden of Disease Study Murray and Lopez. Global Burden of Disease Study Note:Disease burden is measured in disability-adjusted life years (DALYs), a measure that combines the impact on health of years lost due to premature death and years lived with a disability. One DALY is equivalent to one lost year of healthy life The ten leading causes of disease burden in developed countries 1990–2020 Self-inflicted Injuries 10 Stomach cancer Chronic obstructive pulmonary disease 9 Colon and rectal cancers Dementia and other CNS disorders 8 Congenital anomalies Osteoarthritis 7 Lower respiratory infections Alcohol use 6 Perinatal conditions Road traffic accidents 5 Self-inflicted injuries Trachea bronchus & lung cancers 4 Unipolar depression 3 Road traffic accidents Cerebrovascular disease 2 Ischaemic heart disease disease or injury 2 Rank order1990 disease or injury 1 Cardiovascular will remain the leading cause of disease burden

Aim The aim of this study, funded by the National Heart Foundation of Australia, is to implement the evidence-based guidelines into routine clinical practice. A model of care, incorporating a clinical pathway, will be developed to identify depressive symptoms in acute coronary syndrome (ACS) patients at the time of hospital discharge and eight weeks later when assessed in the primary care setting.

Methodology 1.Identification of current activities in Australia and overseas in relation to the development and implementation of clinical pathways for depression and CHD and other co-morbid chronic illness. 2.Gaining management commitment from participating organisations. 3.Creating a Clinical Pathways Team, scoping the Pathway and developing Process Maps. 4.Health Provider Interviews. 5.Discovery Interviews with patients and carers at discharge and 8 weeks. Interviews with GPs of patients at 8 weeks. 6.Identifying best practice model of care for specific patient groups. 7.Pilot implementation of model of care and evaluation of guidelines.

Study Sites South Australia: Mount Gambier Hospital Limestone Coast Division of General Practice Victoria: Wimmera Health Care Group West Vic Division of General Practice Target Numbers 30 patients (+ carers, GPs) in Mount Gambier 30 patients (+ carers, GPs) in Wimmera

Process Mapping the Patient Journey Steps Admission interview with patient and carer Interviews with health staff Eight week interview with patient and carer GP interview at eight weeks Process mapping day

Participants 57 patients (22 Women & 35 Men) 57 carers (mainly spouses and adult children) 18 Health Professionals 18 General Practitioners

GP suggestions to identify acute coronary syndrome patients with psychological issues such as depression Continuity of care (not just a tool to pick up) Ask them specific questions (including family history) Rating scale tool (must be concise as there is not time) Political issues: not enough funding for rural mental health Public awareness, education Time is a problem (may need to tell the receptionist to get a longer consultation)

Conclusions Depression is hard to identify by interview Symptoms seldom volunteered by patient Patients, carers and health care providers generally attribute the symptoms of depression to the heart disease itself Rate of identified depression well below rates reported from studies of hospitalised patients using routine screening

Recommendations When should patients be screened? (a) Prior to discharge (b) 8 weeks from the event and (c) 3 to 6 months from the event What screening tool should be used? HADS and PHQ 9 Who should do the screening? (a) Cardiac rehab nurse (b) GP or Practice nurse Where should patients be screened? (a) Hospital (b) Cardiac rehab (c) Primary care Previous history of depression needs to be assessed

Evidence-based best practice model of care for people with co-morbid depression and coronary heart disease: Pilot implementation plan for Mt Gambier and District Health Service and Limestone Coast Division of General Practice (Hawkins Medical Centre) Pilot Implementation

Chronic Disease Management: Depression and CHD Practice ProtocolNHFA Guideline Database Register of patients Periodic Recall Assessment by Protocol Database Audit of CHD Population

Proposed intervention (modified from Rozanski*) SEVERE MODERATE MILD Stepped Interventions Degree Of Psychosocial Distress Step 3 Step 2 Step 1 Examples Add mental health care specialist, and nurse manager Add BOMH, nurse manager, and adherence promotion (eg telephone follow-up) GP and nurse follow up *Rozanski, et al. Psychosocial Risk Factors in Cardiac Practice. J Am Coll Cardiol 2005;45:637–51